These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7941276)

  • 1. Edrophonium for the antagonism of neuromuscular blockade in dogs.
    Clutton RE
    Vet Rec; 1994 Jun; 134(26):674-8. PubMed ID: 7941276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart rate and rhythm following an edrophonium/atropine mixture for antagonism of neuromuscular blockade during fentanyl/N2O/O2 or isoflurane/N2O/O2 anesthesia.
    Urquhart ML; Ramsey FM; Royster RL; Morell RC; Gerr P
    Anesthesiology; 1987 Oct; 67(4):561-5. PubMed ID: 2889405
    [No Abstract]   [Full Text] [Related]  

  • 3. Edrophonium antagonism of vecuronium at varying degrees of fourth twitch recovery.
    Salib YM; Donati F; Bevan DR
    Can J Anaesth; 1993 Sep; 40(9):839-43. PubMed ID: 8104729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular and autonomic nervous effects of edrophonium and atropine combinations during neuromuscular blockade antagonism in sheep.
    Clutton RE; Glasby MA
    Vet Anaesth Analg; 2008 May; 35(3):191-200. PubMed ID: 18282258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuromuscular blockade with vecuronium and its reversal with edrophonium during total intravenous anesthesia, neuroleptanalgesia and sevoflurane anesthesia].
    Ishii K; Kobayashi T; Kitajima T; Ogata H
    Masui; 1994 Aug; 43(8):1196-200. PubMed ID: 7933501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-responses for edrophonium during antagonism of vecuronium block in young and older adult patients.
    McCarthy GJ; Mirakhur RK; Maddineni VR; McCoy EP
    Anaesthesia; 1995 Jun; 50(6):503-6. PubMed ID: 7618662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Edrophonium: duration of action and atropine requirement in humans during halothane anesthesia.
    Cronnelly R; Morris RB; Miller RD
    Anesthesiology; 1982 Oct; 57(4):261-6. PubMed ID: 7125261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrical and mechanical responses after neuromuscular blockade with vecuronium, and subsequent antagonism with neostigmine or edrophonium.
    Astley BA; Katz RL; Payne JP
    Br J Anaesth; 1987 Aug; 59(8):983-8. PubMed ID: 2888476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Edrophonium priming alters the course of neuromuscular recovery from a pipecuronium neuromuscular blockade.
    Naguib M; Abdulatif M
    Can J Anaesth; 1991 Sep; 38(6):722-7. PubMed ID: 1655299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of pancuronium neuromuscular blockade in halothane-anesthetized ponies using neostigmine and edrophonium.
    Hildebrand SV; Howitt GA
    Am J Vet Res; 1984 Nov; 45(11):2276-80. PubMed ID: 6524720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure to reverse prolonged vecuronium-induced neuromuscular blockade with edrophonium in an anesthetized dog.
    Martin-Flores M; Boesch J; Campoy L; Gleed RD
    J Am Anim Hosp Assoc; 2011; 47(4):294-8. PubMed ID: 21673340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tactile evaluation of train-of-four count as an indicator of reliability of antagonism of vecuronium- or atracurium-induced neuromuscular blockade.
    Kopman AF
    Anesthesiology; 1991 Oct; 75(4):588-93. PubMed ID: 1681762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low and high frequency stimulation tests to characterize the effects of edrophonium on vecuronium-induced neuromuscular block.
    Baurain MJ; Dernovoi BS; d'Hollander AA; Hennart DA; Cantraine FR
    Br J Anaesth; 1995 Jan; 74(1):12-5. PubMed ID: 7880697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response relationships for edrophonium and neostigmine as antagonists of atracurium and vecuronium neuromuscular blockade.
    Smith CE; Donati F; Bevan DR
    Anesthesiology; 1989 Jul; 71(1):37-43. PubMed ID: 2568767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of vecuronium-induced neuromuscular blockade with edrophonium or neostigmine.
    Mirakhur RK; Gibson FM; Lavery GG
    Br J Anaesth; 1987 Apr; 59(4):473-7. PubMed ID: 2882768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade.
    Naguib M; Abdulatif M; al-Ghamdi A
    Anesthesiology; 1993 Oct; 79(4):739-45. PubMed ID: 8214753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neostigmine and edrophonium antagonism of varying intensity neuromuscular blockade induced by atracurium, pancuronium, or vecuronium.
    Rupp SM; McChristian JW; Miller RD; Taboada JA; Cronnelly R
    Anesthesiology; 1986 Jun; 64(6):711-7. PubMed ID: 2872839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of vecuronium paralysis: comparison between edrophonium and neostigmine.
    Dernovoi BS
    Acta Anaesthesiol Belg; 1991; 42(1):65-71. PubMed ID: 1676233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atropine-edrophonium mixture: a dose-response study.
    Naguib M; Gomaa M; Absood GH
    Anesth Analg; 1988 Jul; 67(7):650-5. PubMed ID: 3382038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of profound paralysis: use of large doses of edrophonium to antagonize vecuronium and pancuronium induced neuromuscular blockade.
    Power SJ; Jones RM
    Acta Anaesthesiol Scand; 1989 Aug; 33(6):478-81. PubMed ID: 2572135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.